41118-19-8 Usage
General Description
Methyl 4-oxochromane-6-carboxylate is a chemical compound with the molecular formula C11H10O5. It is a derivative of chroman, a bicyclic organic compound with a unique six-membered ring structure. Methyl 4-oxochromane-6-carboxylate is a ester, meaning it is formed from the reaction of a carboxylic acid and an alcohol. Methyl 4-oxochromane-6-carboxylate has potential applications in the pharmaceutical industry, particularly in the development of novel drugs and medicinal chemistry research. Its chemical structure and properties make it valuable for understanding the reactivity of chromane derivatives and their potential biological activities. Further research and testing are needed to fully explore the potential uses of Methyl 4-oxochromane-6-carboxylate.
Check Digit Verification of cas no
The CAS Registry Mumber 41118-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,1,1 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 41118-19:
(7*4)+(6*1)+(5*1)+(4*1)+(3*8)+(2*1)+(1*9)=78
78 % 10 = 8
So 41118-19-8 is a valid CAS Registry Number.
41118-19-8Relevant articles and documents
ANTIMALARIAL AGENTS
-
Page/Page column 48-49, (2021/02/19)
Methods for treating malaria comprises administration of compounds of Formula (I) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. It also provides uses of the compounds of Formula (I), as defined herein, for inhibiting plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.
SPIROXAZOLIDINONE COMPOUNDS
-
Page/Page column 181, (2012/03/11)
Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.
